DBV Technologies ADR [DBVT] stock is trading at $0.61, up 1.16%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The DBVT shares have gain 20.67% over the last week, with a monthly amount drifted -25.24%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
DBV Technologies ADR [NASDAQ: DBVT] stock has seen the most recent analyst activity on January 04, 2023, when Societe Generale upgraded its rating to a Buy. Previously, Goldman downgraded its rating to Sell on December 16, 2022. On May 10, 2022, downgrade downgraded it’s rating to Neutral and revised its price target to $1.50 on the stock. Societe Generale upgraded its rating to a Buy. Societe Generale downgraded its rating to a Sell. Societe Generale upgraded its rating to Hold for this stock on November 02, 2020. In a note dated August 06, 2020, Societe Generale downgraded an Sell rating on this stock.
DBV Technologies ADR [DBVT] stock has fluctuated between $0.44 and $2.14 over the past year. DBV Technologies ADR [NASDAQ: DBVT] shares were valued at $0.61 at the most recent close of the market.
Analyzing the DBVT fundamentals
Gross Profit Margin for this corporation currently stands at 1.0% with Operating Profit Margin at -9.15%, Pretax Profit Margin comes in at -8.92%, and Net Profit Margin reading is -8.92%. To continue investigating profitability, this company’s Return on Assets is posted at -1.1, Equity is -1.06 and Total Capital is -1.68. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.5587 points at the first support level, and at 0.5044 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.6486, and for the 2nd resistance point, it is at 0.6842.
Ratios To Look Out For
For context, DBV Technologies ADR’s Current Ratio is 2.22. In addition, the Quick Ratio stands at 2.22 and the Cash Ratio stands at 1.5.
Transactions by insiders
Recent insider trading involved Mohideen Pharis, Chief Medical Officer, that happened on Nov 25 ’24 when 565.0 shares were sold. Chief Medical Officer, Mohideen Pharis completed a deal on Nov 22 ’24 to sell 342.0 shares. Meanwhile, Chief Medical Officer Mohideen Pharis sold 2350.0 shares on Nov 21 ’24.
